Makris Michael, Papapostolou Niki, Pasali Maria, Aggelidis Xenofon, Chliva Caterina, Katoulis Alexander C
Allergy Unit "D. Kalogeromitros", 2nd Department of Dermatology and Venereology, Medical School, University General Hospital "Attikon", National and Kapodistrian University of Athens, 12462 Athens, Greece.
2nd Department of Dermatology and Venereology, Medical School, University General Hospital "Attikon", National and Kapodistrian University of Athens, 12462 Athens, Greece.
J Pers Med. 2023 Dec 17;13(12):1719. doi: 10.3390/jpm13121719.
Beta-lactam (BL) antibiotics are among the most prescribed groups of drugs worldwide and have been implicated in a variety of allergic reactions. There is a paucity of literature regarding patient adherence to prescribed instructions following comprehensive allergy assessments.
The objective was to follow up the clinical course of BL allergy in patients who underwent thorough allergological investigation for suspected BL allergy at a tertiary hospital and ascertain patients' compliance with the provided written instructions.
An observational study in patients referred for suspected BL allergy who underwent a comprehensive allergy workup (in vivo ± in vitro tests, DPT in culprit and/or alternative BL) and who subsequently received written instructions was conducted. Data on the nature of the reported drug hypersensitivity reaction, the culprit BL drug, the allergological workup, and the detailed instructions provided in a written drug allergy report were collected retrospectively. Patients' compliance with the instructions was recorded by a telephone survey using a pre-defined questionnaire.
Among the 212 patients meeting the inclusion criteria, 87 patients (72.4% women; mean age 50.1 years; age range 6-84 years) responded to the telephone survey and were included in this study. Surprisingly, 45 out of 87 (51.7%) patients did not adhere to the written instructions. The primary factor contributing to non-compliance was the fear of re-occurrence of a drug-induced allergic reaction (personal and/or triggered by their treating physician reluctance), accounting for 77.7% of cases. The analysis demonstrated that the initial reaction's severity and type, as well as the outcomes of skin testing, did not correlate with compliance to instructions ( > 0.05). Surprisingly enough, a drug provocation test (DPT), irrespectively of the result, emerged as a negative predictor for adherence, with only 40.6% of DPT patients complying compared to 77.8% of those who did not undergo DPT ( = 0.005; odds ratio = 0.195; 95% confidence interval: 0.058-0.655). Variables such as performing DPT with alternative or incriminated drugs or the result of the DPT (positive-negative) were not associated with patient compliance. Conversely, the type of instructions provided exhibited a noteworthy correlation with compliance. Patients who were explicitly instructed to entirely avoid all BL antibiotics demonstrated markedly higher adherence rates (83.3%) compared to those who were advised to have a partial or complete release of BLs (31.8% and 58.1%, respectively; < 0.05). Notably, among compliant patients who received either the original culprit drug or the alternative (32 out of 87, 36.7%), no allergic reactions were reported. In contrast, among the 12 patients with written avoidance of all BLs, subsequent BL intake led to immediate reactions (Grade I and IV) in 2 patients (16.6%).
A notable disparity in patient adherence to written instructions prohibiting or releasing beta-lactams was demonstrated. Less than half of the patients ultimately complied with the provided instructions, underscoring the need for tailored patients' education and strategies to improve adherence in the management of suspected BL allergy.
β-内酰胺(BL)类抗生素是全球处方量最大的药物类别之一,与多种过敏反应有关。关于患者在接受全面过敏评估后对医嘱的依从性,相关文献较少。
对在一家三级医院因疑似BL过敏而接受全面过敏学检查的患者进行BL过敏临床病程随访,并确定患者对所提供书面医嘱的依从性。
对因疑似BL过敏前来就诊并接受全面过敏检查(体内和/或体外试验、对可疑和/或替代BL进行药物激发试验)且随后收到书面医嘱的患者进行了一项观察性研究。回顾性收集了关于所报告药物过敏反应的性质、可疑BL药物、过敏学检查以及书面药物过敏报告中提供的详细医嘱的数据。通过使用预定义问卷的电话调查记录患者对医嘱的依从性。
在符合纳入标准的212例患者中,87例患者(72.4%为女性;平均年龄50.1岁;年龄范围6 - 84岁)回复了电话调查并纳入本研究。令人惊讶的是,87例患者中有45例(51.7%)未遵守书面医嘱。导致不依从的主要因素是担心药物引起的过敏反应再次发生(个人原因和/或因治疗医生的不情愿而引发),占病例的77.7%。分析表明,初始反应的严重程度和类型以及皮肤试验结果与医嘱依从性无关(P>0.05)。令人惊讶的是,无论结果如何,药物激发试验(DPT)都成为依从性的负预测因素,进行DPT的患者中只有40.6%遵守医嘱,而未进行DPT的患者中这一比例为77.8%(P = 0.005;比值比 = 0.195;95%置信区间:0.058 - 0.655)。使用替代药物或可疑药物进行DPT以及DPT结果(阳性 - 阴性)等变量与患者依从性无关。相反,所提供医嘱的类型与依从性呈现出显著相关性。被明确指示完全避免所有BL抗生素的患者的依从率(83.3%)明显高于被建议部分或完全解禁BL的患者(分别为31.8%和58.1%;P<0.05)。值得注意的是,在接受了原始可疑药物或替代药物的依从性患者中(87例中的32例,36.7%),未报告过敏反应。相比之下,在12例书面要求避免所有BL的患者中,随后摄入BL导致2例患者(16.6%)立即出现反应(I级和IV级)。
在患者对禁止或解禁β-内酰胺类药物的书面医嘱的依从性方面存在显著差异。不到一半的患者最终遵守了所提供的医嘱,这突出表明需要进行有针对性的患者教育并制定策略以提高在疑似BL过敏管理中的依从性。